Connect with us

Hi, what are you looking for?

Tuesday, Nov 30, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Cannabis compliance blockchain tech approved in Israel

Global Cannabis Applications’ Efixii technology will be used in cultivation research for Israeli growers

Efixii cannabis compliance tech approved in Israel
Image via GCAC

A Canadian cannabis compliance blockchain technology has been approved by the Israeli government for commercial use.

In a statement Tuesday, B.C.-based Global Cannabis Applications Corp. (GCAC) (CSE: APP.CN) (FSE: 2FA) (OTC: FUAPF) said its Efixii technology will be used in cannabis cultivation research for Israeli growers.

Israeli medical cannabis cultivator Bless Cultivation Ltd., which entered a three-year licensing agreement with the company in 2020, was given approval by the Israeli Medical Cannabis Unit (Yakar) to research the “production capacity of cuttings from a mother plant, without creating a stressful situation for the source plant, as a function of time,” according to GCAC.

Read more: Organigram signs 7-year medical cannabis deal with Israeli firm

“Understanding production capacity of cuttings from a mother plant without stressing the plant will help us develop improved product consistency,” Bless founder Nadav Segal said in a statement. “Efixii is the only service with the power to record and thoroughly analyze this process – all with complete blockchain transparency. This helped us secure approval from the regulator as they are confident in the tamper-proof data Efixii provides.”

The Efixii mobile app will be used to manage, record and deliver “reliable insights across all study periods,” and according to the company, its “methodology has been shown to yield better patient outcomes when its ultra-reliable data is used.”

The app securely logs all data attestations to the blockchain for full transparency.

“GCAC’s artificial intelligence and deep learning algorithms yield important data insights for government research initiatives and help develop a better understanding of cultivation principles,” continues the statement. “This approval allows Bless Cultivation, and others, to immediately commence cultivation without waiting to complete the physical site development (security systems, etc.) thereby lowering the funding burden for cultivation commencement.”

Read more: Aphria joins Israeli medical cannabis rush with new supply deal

In July, GCAC said it would fund cannabis growers that license its Efixii cannabis Seed2Seed blockchain software.

“As we expand our reach within the licensed cannabis community here in Canada, we are seen by more and more cultivators as not just innovators, but also as a trusted service provider,” CEO Brad Moore said in a statement at that time.

GCAC’s stock remained flat Tuesday at $0.065 on the Canadian Securities Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Kathryn Tindale on Twitter

kathryn@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe